Both in Medical Labs
Aclarion vs Biodesix
Over the past year ACON returned −73.5% and BDSX returned +249.0%; their daily moves had a correlation of 0.02.
ACON −73.5% BDSX +249.0%Growth of $1, one year, split-adjusted
| Metric | ACON | BDSX |
|---|---|---|
| Price | $2.04 | $22.86 |
| Market cap | $5.9M | $241.2M |
| Today | +6.25% | +4.15% |
| 1 month | −14.3% | −21.6% |
| 6 months | −37.4% | +132.3% |
| Year to date | −55.7% | +236.2% |
| 1 year | −73.3% | +243.8% |
| Revenue growth (YoY) | +30.5% | +34.2% |
| Gross margin | 32.9% | 82.1% |
| Net margin | −10899.5% | −27.1% |
| P/E (TTM) | — | — |
| Price / sales | 70.2× | 2.3× |
| Net cash | $16.3M | -$16.8M |
| Dividend yield | — | — |
| Volatility (60d) | 67.7% | 74.8% |
| Short % of float | 0.9% | 4.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).